Insider Transactions in Q2 2024 at Kiromic Biopharma, Inc. (KRBP)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
Brian Hungerford Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.67%
|
$2,000
$2.6 P/Share
|
|
Jun 12
2024
|
Pamela Misajon Director |
BUY
Open market or private purchase
|
Direct |
1,610
+2.73%
|
$4,830
$3.27 P/Share
|
|
Jun 12
2024
|
Pietro Bersani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+2.12%
|
$9,000
$3.28 P/Share
|
|
Jun 12
2024
|
Brian Hungerford Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.7%
|
$3,000
$3.18 P/Share
|
|
Jun 11
2024
|
Pietro Bersani Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+2.16%
|
$9,000
$3.23 P/Share
|
|
Jun 11
2024
|
Michael Nagel Director |
BUY
Open market or private purchase
|
Direct |
1,000
+2.26%
|
$3,000
$3.33 P/Share
|
|
Jun 10
2024
|
Pamela Misajon Director |
BUY
Open market or private purchase
|
Direct |
1,701
+5.89%
|
$3,402
$2.93 P/Share
|
|
May 03
2024
|
Brian Hungerford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,933
+38.89%
|
-
|
|
May 03
2024
|
Pietro Bersani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,968
+50.0%
|
-
|